SOL-LUTION
DEAD

Serial Number

79160999

Owner

BIONORICA SE

Filing Date

Oct 9, 2014

Add to watchlist:

No watchlists yet
View on USPTO

SOL-LUTION Trademark

Serial Number: 79160999 • Registration: 5024394

SOL-LUTION is a trademark filed by BIONORICA SE on October 9, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

BIONORICA SE (41 trademarks)

KERSCHENSTEINERSTRAßE 11-15
NEUMARKT 92318 , DE

Entity Type: 94

Dermapharm Aktiengesellschaft (10 trademarks)

Lil-Dagover-Ring 7

Entity Type: 98

Spectrum Therapeutics GmbH (2 trademarks)

Kerschensteinerstr. 11-15

Entity Type: 98

Bionorica Ethics GmbH (2 trademarks)

Kerschensteinerstr. 11-15

Entity Type: 99

Trademark Details

Filing Date

October 9, 2014

Registration Date

August 23, 2016

Published for Opposition

June 7, 2016

Cancellation Date

October 9, 2024

Goods & Services

Pharmaceutical preparations for the treatment of gingivitis, emesis, neuropathic pain, muscle spasticity, neurodermatitis, psoriasis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhoea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynaecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, premenstrual syndrome, climateric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, climactic sleep disturbances, depressive moods, protection of the skeletal system, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, nephrolithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, arthritis, osteoarthritis, fever, cough, cold, Alzheimer's disease, infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries, occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; medical and veterinary preparations and articles, namely, preparations for the treatment of gingivitis, emesis, neuropathic pain, muscle spasticity, neurodermatitis, psoriasis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhoea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynaecological disorders affecting menstruation, sterility, menstruation syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, premenstrual syndrome, climateric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, climactic sleep disturbances, depressive moods, protection of the skeletal system, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, nephrolithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, arthritis, osteoarthritis, fever, cough, cold, Alzheimer's disease, infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries, occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older, articles being medical plasters, medical materials for dressings, namely, gauze and bandages; dietetic preparations, namely, dietetic sugar for medical use, dietary and nutritional supplements used for weight loss, protein supplement shakes for weight gain purposes, chocolate-based meal replacement shakes for weight loss purposes; dietetic food and substances adapted for medical or veterinary use, namely, dietetic herbal teas, vitamin and mineral supplements, dietic food supplements based on amino acids, minerals and/or trace elements, dietary vitamin and mineral beverages; dietary supplements; dental preparations and articles, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of medicated balms, medicated dental tapes, medicated dental ribbons, medicated dental polish, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria and caries, diagnostic reagents for detecting derivatives from caries-causing bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers, material for stopping teeth, dental wax

Equity financing services for start-up companies and small businesses in the field of pharmacy, nutritional supplements, cosmetics, food, drinks and plant extracts

Business management; business administration; office functions; advertising; marketing and promotional services; business contact services, namely, provision of commercial and business contact information, connecting qualified service providers with consumers, arranging of contractual services with third parties, providing an online computer database in the field of business information and business contacts; collective buying services, namely, purchasing pharmaceutical preparations, medical and veterinary preparations and articles, dietetic preparations, dietetic food and drinks, dietary and nutritional supplements, and cosmetics for others; commercial evaluation services, namely, evaluation relating to commercial matters; distributorship services in the field of pharmaceutical preparations, medical and veterinary preparations and articles, dietetic preparations, dietetic food and drinks, dietary and nutritional supplements, and cosmetics; import and export services; negotiation and conclusion of commercial transactions for third parties; procurement services for others, namely, purchasing pharmacy furniture and devices; business assistance, business management and administrative services, namely, processing of purchase orders, filing business formation documents; business analysis, research and information services; business auditing; business mediation services for third parties; advice, consultancy and information for the aforesaid

Licensing and authority services, namely, licensing of intellectual property; legal registration services-, namely, domain name registration services; and registration of company names; legal services; advice, consultancy and information for the aforesaid, included in this class

Development of pharmaceutical preparations and medicines; IT services, namely, software development, programming and implementation, computer hardware development, hosting services, namely, hosting of websites; software as a service featuring software for use in database management, for accounting, for financial analysis, and rental of software-; rental of computer hardware and computer peripherals; IT consultancy, advisory and information services, IT security, namely, testing of security systems, maintenance of computer software relating to computer security and prevention of computer risks, media data duplication and conversion services of electronic information; data coding, namely, data encryption services; computer system analysis and diagnostics; research, development and implementation of computers and systems; computer project management services; data mining; digital watermarking; computer consultation services; technological services relating to computers, namely, technological planning and consulting services in the field of computer hardware systems; computer network configuration services; updating of memory banks of computer systems; data migration services; updating websites for others; monitoring of computer systems by remote access to ensure proper functioning; testing, authentication and quality control, namely, product safety testing, product quality testing, testing, inspection or research of pharmaceuticals to ensure compliance with pharmaceutical and medical standards; design services, namely, color analysis for purposes of interior design of pharmacies, design of web sites for others, design of home pages, design of interior decor of pharmacies; all aforesaid services not in relation to consultancy in regard of building design services and building construction; rental of computer hard and computer software; leasing of computer programs, leasing of computers

Filing History

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 20, 2025 LIMN
DEATH OF INTERNATIONAL REGISTRATION
Apr 25, 2025 DETH
LIMITATION OF GOODS RECEIVED FROM IB
Oct 26, 2024 LIMG
CHANGE OF OWNER RECEIVED FROM IB
Oct 17, 2024 CHLD
CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 9, 2024 ADCH
TOTAL INVALIDATION PROCESSED BY THE IB
Nov 26, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 3, 2023 INTS
INVALIDATION PROCESSED
Nov 3, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 3, 2023 INTR
CANCELLED SECTION 71
Mar 3, 2023 C71T
NEW REPRESENTATIVE AT IB RECEIVED
May 21, 2022 NREP
CHANGE OF OWNER RECEIVED FROM IB
Jul 4, 2019 CHLD
NOTIFICATION PROCESSED BY IB
Jul 8, 2017 GPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 17, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 26, 2017 FICS
FINAL DISPOSITION PROCESSED
Jan 26, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 23, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 23, 2016 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 12, 2016 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 27, 2016 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 27, 2016 OPNR
PUBLISHED FOR OPPOSITION
Jun 7, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 18, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 18, 2016 OP2R
NOTICE OF PUBLICATION
May 18, 2016 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 4, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2016 CNSA
AMENDMENT FROM APPLICANT ENTERED
Apr 27, 2016 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2016 CRFA
PAPER RECEIVED
Apr 18, 2016 MAIL
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Nov 16, 2015 LIMN
FINAL REFUSAL MAILED
Oct 27, 2015 CNFR
FINAL REFUSAL WRITTEN
Oct 26, 2015 CNFR
LIMITATION OF GOODS RECEIVED FROM IB
Oct 23, 2015 LIMG
DATA MODIFICATION COMPLETED
Oct 20, 2015 DMCC
AMENDMENT FROM APPLICANT ENTERED
Oct 20, 2015 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2015 CRFA
ASSIGNED TO LIE
Sep 18, 2015 ALIE
PAPER RECEIVED
Sep 3, 2015 MAIL
REFUSAL PROCESSED BY IB
Mar 27, 2015 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 9, 2015 RFCS
REFUSAL PROCESSED BY MPU
Mar 9, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 7, 2015 RFCR
NON-FINAL ACTION WRITTEN
Mar 6, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 3, 2015 MAFR
ASSIGNED TO EXAMINER
Feb 27, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 26, 2015 REPR